Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nathalie Krecké"'
Publikováno v:
Dermatology and Therapy
The human papillomavirus (HPV), of which more than 200 different types have so far been identified, is an infectious disease impacting skin and mucous membranes. Several genera exist with distinct clinical impact. However, with ornamental tattoos inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2960c87d380859f60641042cf52f04
https://doi.org/10.1007/s13555-017-0197-y
https://doi.org/10.1007/s13555-017-0197-y
Autor:
Jasna Bingulac-Popović, Manuela Miletić, Margareta Maslovic, Katrin Fleischhauer, Bernard Schroeter, Ulrik Sprogøe, Ivana Babić, Kirstin Stüpmann, Jan Schroeter, Hermann Eichler, Hana Safic Stanic, Christoffer Dellgren, Nina Juraković-Lončar, Tomislav Vuk, Thomas Vogt, Mark H. Yazer, Nathalie Krecké, Vesna Dogic, Druck, Barbara Burgard, Tino Schulz, Irena Jukić, Cornelia S. L. Müller, Ralf Knels, Jens Hiller, Claudia Pföhler, Jan Klerke, Axel Pruß, J. Kardoeus, Maja Strauss-Patko
Publikováno v:
Transfusion Medicine and Hemotherapy. 44:437-439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5dbd8702d7d5e99a659a9e50c72481f
https://doi.org/10.1159/000485268
https://doi.org/10.1159/000485268
Autor:
Cornelia S. L. Müller, Hermann Eichler, Barbara Burgard, Claudia Pföhler, Nathalie Krecké, Thomas Vogt
Publikováno v:
Transfusion Medicine and Hemotherapy. 44:426-428
Background: Checkpoint blocking agents such as pembrolizumab or nivolumab may induce a diversity of mostly autoimmune-mediated side effects. These autoimmune phenomena mainly affect ductless glands such as the pituitary gland (hypophysitis), the thyr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defbf5322911a9d618a2d511e0c3c1ec
https://doi.org/10.1159/000479237
https://doi.org/10.1159/000479237
Autor:
Thomas Vogt, Nathalie Krecké, Anna Zimmer, Bettina Friesenhahn-Ochs, Claudia Pföhler, Cornelia S. L. Müller
Publikováno v:
Dermato-endocrinology
Ipilimumab is an anti-CTLA-4 antibody that is approved for the treatment of metastatic malignant melanoma. Side-effects are mostly immune-mediated and in many cases the lack of specific symptoms leads to delayed diagnosis and treatment of adverse eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4330ff31ebde474a260f7a170152137a
https://doi.org/10.1080/19381980.2016.1199307
https://doi.org/10.1080/19381980.2016.1199307